Drug Channels

OCTOBER 1, 2024

Last week, the Federal Trade Commission (FTC) released the redacted version of administrative complaint against the three largest pharmacy benefit managers (PBMs). The Food & Drug Administration (FDA) recently approved the first interchangeable biosimilar insulin product: the insulin glargine-yfgn injection from Viatris.

Insulin 40

Insulin Branding Production Pharmacy 40

Druggist

OCTOBER 4, 2020

Most of the drugs which are recommended in the symptomatic management of IBS can be purchased over the counter from pharmacies, supermarkets and online. Customers may need to get larger Fybogel packs from a pharmacy counter as products available for self-selection may be smaller in size. Some of them may be cheaper than Fybogel brand.

Containment 98

Containment Pharmacy Bacteria Sales 98

pharmaphorum

JANUARY 6, 2023

On 14th November 2022, Eli Lilly apparently wrote on its Twitter account, “We are excited to announce insulin is free now.” It was one of many fake branded accounts that took advantage of Twitter users’ sudden ability to purchase a “verified” check mark for $8.

Manufacturing 105

Manufacturing Sales Insulin Drugs 105

pharmaphorum

APRIL 1, 2022

Semglee (insulin glargine-yfgn) is the first biosimilar available at the retail pharmacy counter, and it obtained interchangeable status. And, manufacturers will likely pay close attention to the impact of Semglee’s interchangeable designation on the adoption of biosimilars in the retail pharmacy space.

Marketing 59

Marketing Pharmacy FDA Approval Manufacturing 59

Druggist

MAY 12, 2021

Unfortunately, Celevac was discontinued , and now it is impossible to get it on prescription or purchase from the pharmacy. Celevac is a brand of tablets containing methylcellulose. In pharmacy, methylcellulose is mainly used in the treatment of constipation. What is Celevac? Methylcellulose is composed of insoluble fiber.

Containment 97

Containment Production Pharmacy Licensing 97

Pharmaceutical Technology

MARCH 8, 2023

Eli Lilly has announced that it will reduce the price of its most commonly used insulin, Humalog, in the US, by 70% and cap the out-of-pocket cost for those on commercial insurance at $35. This is the second time Lilly has significantly reduced the cost of its insulin, as in 2019 the company reduced the list price of Humalog by 50%.

Insulin 264

Insulin Branding Marketing Pharmacy 264

pharmaphorum

APRIL 13, 2022

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. Insulin rationing. In the US, approximately 37.3

Insulin 130

Insulin Drugs Production Hormones 130

XTalks

FEBRUARY 8, 2021

Like generic forms of synthetic pharmaceuticals, biosimilars have the advantage of being less costly compared to their branded counterparts. As a subset of biosimilars, interchangeable biological products can be substituted for the reference product at the pharmacy level, without the input of the prescribing physician.

Production 78

Production Insulin Branding Generic Drugs 78

STAT News

NOVEMBER 18, 2022

The monoclonal antibody teplizumab, which will be marketed under the brand name Tzield and is from ProventionBio and Sanofi, is given through intravenous infusion. Diabetic patients will now have easier access to insulin after the FDA approved an Eli Lilly biosimilar as interchangeable with the biologic drug , Bloomberg News notes. Rezvoglar,

Insulin 98

Insulin FDA Approval Production Pharmacy 98

pharmaphorum

APRIL 7, 2022

Last week, a bill to limit the cost of insulin in the US passed the House of Representatives, taking Democrats one step closer to fulfilling their promise of lowering drug costs. The only way you can see to cut back is to cut back on your insulin. Right now, it takes over $2,000 out-of-pocket a month,” she said. Progress or missteps?

Medicine 52

Medicine Insulin Pharmacy Doctors 52

XTalks

FEBRUARY 2, 2023

Amjevita will be offered at two price points — the branded version that is five percent cheaper than Humira’s monthly price of $6,922 and an unbranded form that is 55 percent less.

Marketing 52

Marketing FDA Approval Branding Drugs 52

FDA Law Blog

AUGUST 14, 2022

The negotiations will result in a Maximum Fair Price (“MFP”) that the manufacturer must make available to providers furnishing the drug under Medicare Part B or pharmacies dispensing the drug under Part D.

Drugs 98

Drugs Manufacturing Insulin Pharmacy 98

The Pharma Data

MAY 13, 2021

I Have A Doctorate In Pharmacy, But Everything I Learned About Pain Relief In Pharmacy School Is Dead Wrong! Which is how I got into pharmacy — after all, what better way to spend your life than by removing illness from the world. . … And then got my Doctor of Pharmacy (Pharm. Stimulates DNA and RNA synthesis.

Production 52

Production Pharmacy Doctors Doctor 52

Pharmacy Checkers

MARCH 11, 2020

Founded in 2002, and launching its website in 2003, PharmacyChecker provides consumers with online pharmacy verification and comparative drug price information to help them make the best decisions for themselves and their families on how to afford prescription drugs. counterparts.

Pharmacy 41

Pharmacy Drugs FDA Approval Licensing 41